These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 6837416

  • 1. Acute and chronic effects of verapamil in patients with paroxysmal supraventricular tachycardia.
    Sakurai M, Yasuda H, Kato N, Nomura A, Fujita M, Nishino T, Fujita K, Koike Y, Saito H.
    Am Heart J; 1983 Apr; 105(4):619-28. PubMed ID: 6837416
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the electrophysiologic effects of oral sustained-release and intravenous verapamil in patients with paroxysmal supraventricular tachycardia.
    Lai WT, Voon WC, Yen HW, Chang JS, Sheu SH, Hwang YS, Chiu HF.
    Am J Cardiol; 1993 Feb 15; 71(5):405-8. PubMed ID: 8430627
    [Abstract] [Full Text] [Related]

  • 3. Effect of verapamil studied by programmed electrical stimulation of the heart in patients with paroxysmal re-entrant supraventricular tachycardia.
    Wellens HJ, Tan SL, Bär FW, Düren DR, Lie KI, Dohmen HM.
    Br Heart J; 1977 Oct 15; 39(10):1058-66. PubMed ID: 911555
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of paroxysmal reentrant supraventricular tachycardia with flecainide acetate.
    Kim SS, Lal R, Ruffy R.
    Am J Cardiol; 1986 Jul 01; 58(1):80-5. PubMed ID: 3728336
    [Abstract] [Full Text] [Related]

  • 6. Effects of verapamil on supraventricular tachycardia in patients with overt and concealed Wolff-Parkinson-White syndrome.
    Hamer A, Peter T, Platt M, Mandel WJ.
    Am Heart J; 1981 May 01; 101(5):600-12. PubMed ID: 7223599
    [Abstract] [Full Text] [Related]

  • 7. The prophylaxis of AV nodal re-entry tachycardia.
    Tonkin AM, Shorne L.
    Clin Exp Pharmacol Physiol Suppl; 1982 May 01; 6():135-43. PubMed ID: 6956473
    [Abstract] [Full Text] [Related]

  • 8. Epinephrine-induced reversal of verapamil's electrophysiologic and therapeutic effects in patients with paroxysmal supraventricular tachycardia.
    Morady F, Kou WH, Kadish AH, Toivonen LK, Kushner JA, Schmaltz S.
    Circulation; 1989 Apr 01; 79(4):783-90. PubMed ID: 2924411
    [Abstract] [Full Text] [Related]

  • 9. [Effects of verapamil and disopyramide phosphate on the termination, reinduction and long-term prevention of paroxysmal supraventricular tachycardia].
    Tsuchioka Y, Nakagawa H, Yamagata T, Sakura E, Hashimoto M, Okamoto M, Matsuura H, Kajiyama G.
    Kokyu To Junkan; 1990 Mar 01; 38(3):243-8. PubMed ID: 2109870
    [Abstract] [Full Text] [Related]

  • 10. Comparative clinical and electrophysiologic effects of adenosine triphosphate and verapamil on paroxysmal reciprocating junctional tachycardia.
    Belhassen B, Glick A, Laniado S.
    Circulation; 1988 Apr 01; 77(4):795-805. PubMed ID: 3349581
    [Abstract] [Full Text] [Related]

  • 11. Intraindividual comparison of diltiazem and verapamil on induction of paroxysmal supraventricular tachycardia.
    Rizos I, Seidl KH, Aidonidis I, Stamou S, Senges J, Toutouzas P.
    Cardiology; 1994 Apr 01; 85(6):388-96. PubMed ID: 7697674
    [Abstract] [Full Text] [Related]

  • 12. Verapamil in prophylaxis of paroxysmal atrioventricular nodal reentrant tachycardia.
    Tonkin AM, Aylward PE, Joel SE, Heddle WF.
    J Cardiovasc Pharmacol; 1980 Apr 01; 2(5):473-86. PubMed ID: 6157944
    [Abstract] [Full Text] [Related]

  • 13. Intravenous verapamil for termination of re-entrant supraventricular tachycardias: intracardiac studies correlated with plasma verapamil concentrations.
    Sung RJ, Elser B, McAllister RG.
    Ann Intern Med; 1980 Nov 01; 93(5):682-9. PubMed ID: 7212475
    [Abstract] [Full Text] [Related]

  • 14. Usefulness of programmed stimulation in predicting efficacy of propafenone in long-term antiarrhythmic therapy for paroxysmal supraventricular tachycardia.
    Manz M, Steinbeck G, Lüderitz B.
    Am J Cardiol; 1985 Oct 01; 56(10):593-7. PubMed ID: 4050693
    [Abstract] [Full Text] [Related]

  • 15. Adenosine for paroxysmal supraventricular tachycardia: dose ranging and comparison with verapamil. Assessment in placebo-controlled, multicenter trials. The Adenosine for PSVT Study Group.
    DiMarco JP, Miles W, Akhtar M, Milstein S, Sharma AD, Platia E, McGovern B, Scheinman MM, Govier WC.
    Ann Intern Med; 1990 Jul 15; 113(2):104-10. PubMed ID: 2193560
    [Abstract] [Full Text] [Related]

  • 16. Effects of oral verapamil in patients with atrioventricular reentrant tachycardia incorporating an accessory pathway.
    Wu D, Kou HC, Yeh SJ, Lin FC, Hung JS.
    Circulation; 1983 Feb 15; 67(2):426-33. PubMed ID: 6848233
    [Abstract] [Full Text] [Related]

  • 17. Effects of diltiazem, verapamil, and inhalation anesthetics on electrophysiologic properties affecting reentrant supraventricular tachycardia in chronically instrumented dogs.
    Atlee JL, Bosnjak ZJ, Yeager TS.
    Anesthesiology; 1990 May 15; 72(5):889-901. PubMed ID: 2339803
    [Abstract] [Full Text] [Related]

  • 18. Usefulness of invasive and non-invasive electrophysiologic studies in the selection of antiarrhythmic drugs for the patients with paroxysmal supraventricular tachyarrhythmia.
    Satake S, Hiejima K, Moroi Y, Hirao K, Kubo I, Suzuki F, Suzuki F.
    Jpn Circ J; 1985 Mar 15; 49(3):345-50. PubMed ID: 3981793
    [Abstract] [Full Text] [Related]

  • 19. Comparative clinical and electrophysiologic effects of adenosine and verapamil on termination of paroxysmal supraventricular tachycardia.
    Sethi KK, Singh B, Kalra GS, Arora R, Khalilullah M.
    Indian Heart J; 1994 Mar 15; 46(3):141-4. PubMed ID: 7821934
    [Abstract] [Full Text] [Related]

  • 20. Acute conversion of paroxysmal supraventricular tachycardia with intravenous diltiazem. IV Diltiazem Study Group.
    Dougherty AH, Jackman WM, Naccarelli GV, Friday KJ, Dias VC.
    Am J Cardiol; 1992 Sep 01; 70(6):587-92. PubMed ID: 1510006
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.